Tibet Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the research, development, manufacturing and marketing of modernized traditional Tibetan medicines. The company employs 190 full-time employees The company went IPO on 2011-01-25. The firm is mainly engaged in sales of its products principally to distributors, which in turn sell to hospitals, hospital pharmacies, and retail pharmacies.
TBET stock price ended at $0 on 星期一, after rising NaN%
On the latest trading day Dec 30, 2024, the stock price of TBET rose by NaN%, climbing from $0.00 to $0.00. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $0.00 and a high of $0.00. Notably, trading volume dropped by 5.6K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 6.6K shares were traded, equating to a market value of approximately --.